Recent Posts
Connect with:
Monday / April 15.
HomemiproductsOptiLight OPT Technology

OptiLight OPT Technology

Lumenis, the inventor of intense pulsed light (IPL), presents OptiLight, the first and only IPL that has been approved by the United States Food and Drug Administration and listed by the Therapeutic Goods Administration for the management of dry eye disease due to meibomian gland deficiency.

OptiLight elevates dry eye management with Lumenis’ patented optimal pulse technology (OPT) and user-centred design. Get the safe, precise, elegant procedure you want and the comfortable, effective therapy your patients need to manage dry eye disease with OptiLight.

Contact: Lumenis (AUS) 1800 586 364 or (NZ) 0800 239 015